Interactions of flavonoids and other phytochemicals with adenosine receptors

Journal of Medicinal Chemistry

Volumn 39, Issue 3, 1996, Pages 781-788

  Ji, Xiao Duo ^a   Melman, Neli ^a   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N (3 IODOBENZYL)ADENOSINE 5' (N METHYLURONAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ALPHA NAPHTHOFLAVONE; FLAVONE DERIVATIVE; GALANGIN; GENISTEIN; HEMATOXYLIN; PHENYLISOPROPYLADENOSINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; NONHUMAN; PHYTOCHEMISTRY; RAT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL LINE; CHO CELLS; CRICETINAE; FLAVONOIDS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PLANTS; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RECEPTORS, PURINERGIC P1;

EID: 0030051539     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950661k     Document Type: Article

References (52)

1. Drury, A. N.; Szent-Gyorgyi, A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J. Physiol. 1929, 68, 213-237.
2. Jacobson, K. A.; van Galen, P. J. M.; Williams, M. Adenosine receptors - pharmacology, structure activity relationships, and therapeutic potential. J. Med. Chem. 1992, 35, 407-422.
3. von Lubitz, D. K. J. E.; Jacobson, K. A. Behavioral effects of adenosine receptor stimulation. In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, Bellardinelli, L., Pelleg, A., Eds.; Kluwer: Norwell, 1995; pp 489-498.
4. Jacobson, M. A. Cloning and expression of human adenosine receptor subtypes. In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology; Bellardinelli, L., Pelleg, A., Eds.; Kluwer: Norwell, 1995; pp 5-13.
5. 1 adenosine receptor in the anaesthetised pig: pharmacological and therapeutic implications. Cardiovasc. Res. 1994, 28, 621-628.
6. Suzuki, F.; Shimada, J.; Mizumoto, H.; Karasawa, A.; Kubo, K.; Nonaka, H.; Ishii, A.; Kawakita, T. Adenosine-A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure. J. Med. Chem. 1992, 35, 3066-3075.
7. 6-p-sulfophenylalkyl- and derivatives of adenosine: Water soluble and peripherally selective adenosine agonists. J. Med. Chem. 1992, 35, 4143-4149.
8. Hutchison, A. J.; Williams, M.; Jesus, R. d.; Yokoyama, R.; Oei, H. H.; Ghai, G. R.; Webb, R. L.; Zoganas, H. C.; Stone, G. A.; Jarvis, M. F. 2-(Arylalkylamino)adenosin-5′-uronamides: a new class of highly selective adenosine A2 receptor ligands. J. Med. Chem. 1990, 33, 1919-1924.
9. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 7432-7436.
10. Hannon, J. P.; Pfannkuche, H. J.; Fozard, J. R. A role for mast-cells in adenosine A(3) receptor-mediated hypotension in the rat. Br. J. Pharmacol. 1995, 115, 945-952.
11. 3-adenosine receptors: Mediation of behavioral depressant effects. FEBS Lett. 1993, 336, 57-60.
12. 3-adenosine receptors. J. Med. Chem. 1994, 37, 636-646.
13. Beaven, M. A.; Ramkumar, V.; Ali, H. Adenosine-A(3) receptors in mast-cells. Trends Pharmacol. Sci. 1994, 15, 13-14.
14. 3 adenosine receptors. J. Med. Chem. 1994, 37, 3373-3382.
15. 2-adenosine receptors. Biochem. Pharmacol. 1988, 37, 655-64.
16. Francis, J. E.; Cash, W. D.; Psychoyos, S.; Ghai, G.; Wenk, P.; Friedmann, R. C.; Atkins, C.; Warren, V.; Furness, P.; Hyun, J. L. Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists. J. Med. Chem. 1988, 31, 1014-1020.
17. 1-Adenosine Receptor. J. Med. Chem. 1991, 34, 2877-2882.
18. 2A adenosine receptor antagonists. Bioorg. Med. Chem. Lett. 1994, 4, 2539-2544.
19. Poucher, S. M.; Keddie, J. R.; Singh, P.; Stoggall, S. M.; Caulkett, P. W. R.; Jones, G.; Collis, M. G. The in-vitro pharmacology of ZM241385, a potent, nonxanthine, A(2a) selective adenosine receptor antagonist. Br. J. Pharmacol. 1995, 115, 1096-1102.
20. Siddiqi, S. M.; Ji, X. d.; Melman, N.; Olah, M. E., Jain, R.; Evans, P.; Glashofer, M.; Padgett, W. L.; Cohen, L. A.; Daly, J. W.; Stiles, G. L.; Jacobson, K. A. A survey of non-xanthnine derivatives as adenosine receptor ligands. Nucleosides Nucleotides 1996, 15, 693-718.
21. 1-purinergic (adenosine) receptor in FRTL-5 thyroid cells. Biochem. Biophys. Res. Commun. 1994, 203, 1488-1495.
22. 1 receptor ligand isolated from Salvia Militorrhiza bunge (Danshen). Tetrahedron Lett. 1991, 32, 2061-2064.
23. van Rhee, A. M.; Siddiqi, S. M.; Melman, N.; Shi, D.; Padgett, W. L.; Daly, J. W.; Jacobson, K. A. Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists. J. Med. Chem. 1996, 39, 398-406.
24. Gabor M. Anti-inflammatory and anti-allergic properties of flavonoids. Prog. Clin. Biol. Res. 1986, 213, 471-80.
25. (a) Hertog, M. G.; Feskens, E. J.; Hollman, P.C.; Katan, M.B.; Kromhout, D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342, 1007-1011.
26. (b) Limasset, B.; le Doucen, C.; Dore, J.C.; Ojasoo, T.; Damon, M.; Crastes de Paulet, A. Effects of flavonoids on the release of reactive oxygen species by stimulated human neutrophils. Multivariate analysis of structure-activity relationships (SAR). Biochem. Pharmacol. 1993, 46, 1257-1271.
27. Middleton, E. and Kandaswami, C. Effect of flavonoids on immune and inflammatory cell function. Biochem. Pharmacol. 1992, 43, 1167-1179.
28. Critchfield, J. W.; Welsh, C. J.; Phang, J. M.; Yeh, G. C. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem. Pharmacol. 1994, 48, 1437-1445.
29. (a) Kingston, D. G. I.; Fales, H. M. Methane chemical ionization mass spectrometry of flavonoids. Tetrahedron 1973, 29, 4083-4086.
30. (b) Rao, M. M.; Kingston, D. G. I.; Spittler, T. D. Flavonoids from fluorensia cerua. Phytochemistry 1970, 9, 227-228.
31. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 1101-1111.
32. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 978-982.
33. 6-phenylisopropyladenosine. Naunyn-Schmiedeberg's Arch. Pharmacol. 1980, 313, 179-187.
34. 2 receptors in rat brain tissue. J. Pharmacol. Exp. Ther. 1989, 251, 888-893.
35. 50) of an enzyme reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
36. Fales, H. M.; Warnhoff, E. W.; Wildman, W. C. Alkaloids of the Amaryllidaceae. VI. The action of oxidizing agents on lycorine and caranine. J. Amer. Chem. Soc. 1955, 77, 5885-5890.
37. Fales, H. M.; Wildman, W. C. Alkaloids of the Amaryllidaceae. IX. On tbe structure of galanthine. J. Am. Chem. Soc. 1956, 78, 4151-4153.
38. Fales, H. M.; Wildman, W. C. Structure of haemanthamine. Chem. Ind. (London) 1958, 561-562.
39. Craig, J. C.; Naik, A. R.; Pratt, R.; Johnson, E.; Bhacca, N. S. Nuclear magnetic resonace spectra and stereochemistry of the antibacterial principle from Haematoxylon braziletto. J. Org. Chem. 1965, 30, 1573-1576.
40. (a) Johne, S.; Bernasch, H.; Groger, D. Biosynthesis of the acridine alkaloid arborinine. Pharmazie 1970, 25, 777-779.
41. (b) Banerjee, S. K.; Chakravarti, R. N. Norarborinine, a demethylation product of arborinine. Bull. Calcutta Sch. Trop. Med. 1965, 13, 60.
42. Roger, C. R. The nutritional incidence of flavonoids: some physiological and metabolic considerations. Experientia 1988, 44, 725-733.
43. Middleton, E., Jr. Some biological properties of plant flavonoids. Ann. Allergy 1988, 61, 53-57.
44. Beretz, A.; Cazenave, J. P. The effect of flavonoids on blood-vessel wall interactions. Prog. Clin. Biol. Res. 1988, 280, 187-200.
45. Jaeger, A.; Walti, M.; Neftel, K Side effects of flavonoids in medical practice. Prog. Clin. Biol. Res 1988, 280, 379-394.
46. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365-10369.
47. 3 adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 1995, 20, 689-699.
48. Burnstock, G. in P2 Purinoceptors: Localization, Function, and Transduction Mechanisms; CIBA Foundation Symposium; 1996, in press.
49. Kuppusamy, U. R.; Das, N. P. Potentiation of beta-adrenoceptor agonist-mediated lipolysis by quercetin and fisetin in isolated rat adipocytes. Biochem. Pharmacol. 1994, 47, 521-529.
50. Koch, H. P.; Jager, W.; Groh, U.; Plank, G. In vitro inhibition of adenosine deaminase by flavonoids and related compounds. New insight into the mechanism of action of plant phenolics. Methods Find. Exp. Clin. Pharmacol. 1992, 14, 413-417.
51. Kondo, H.; Ikeda, T., Taga, J. Annu. Rep. ITSUU Labs. 1952, 3, 65-69; Chem. Abstr. 1953, 7517b.
52. Kondo, H.; Ikeda, T., Taga, J. Annu. Rep. ITSUU Labs. 1952, 3, 65-69; Chem. Abstr. 1953, 7517b.